Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Acuity Brands, Inc. (AYI) Posts Earnings Beat: Were The Hedge Funds Right About This Stock?

Page 1 of 2

Acuity Brands, Inc. (NYSE:AYI) stock has already jumped by more than 28% so far this year and that trend is unlikely to wane, as Acuity Brands posted strong earnings this morning for its fiscal third quarter of 2015, which ended on May 31. The company, which provides lighting solutions for a variety of consumer and business segments, reported diluted EPS of $1.48 for the quarter, 47% more than the same period a year ago. That figure also handily beat the consensus EPS estimate EPS of $1.34. The company’s revenue increased by 13% year-over-year to $683.7 million, but came slightly short of the consensus forecast of $686.94 million. Heading into this earnings release, there were a lot of upgrades from analysts for Acuity Brands, Inc. (NYSE:AYI) in the last few days. Stifel Nicolaus analyst set a price target of $188 to $195 on the stock with a ‘Buy’ rating on Tuesday, while Canaccord Genuity analysts set a price target of $192 on the stock with a ‘Buy’ rating on Monday.

abacus, earnings, money, counting

Hedge funds were also bullishly expanding their positions in the stock heading towards this earnings report, as there were 32 hedge funds holding long positions in the stock at the end of first quarter, which was up from 28 at the end of the fourth quarter. There was also a 36% increase in aggregate capital invested by these hedge funds, with them holding $460.98 million in shares by the end of the first quarter. While Acuity Brands, Inc. (NYSE:AYI)’s shares increased by 19% in the first quarter, the overall increase shows the smart money was not just benefiting from the gains, but adding onto their positions. Shares were up by another 7% in the second quarter.

Most investors don’t understand hedge funds and indicators that are based on hedge fund and insider activity. They ignore hedge funds because of their recent poor performance in the long-running bull market. Our research indicates that hedge funds underperformed because they aren’t 100% long. Hedge fund fees are also very large compared to the returns generated and they reduce the net returns enjoyed (or not) by investors. We uncovered through extensive research that hedge funds’ long positions in small-cap stocks actually greatly outperformed the market from 1999 to 2012, and built a system around this. The 15 most popular small-cap stocks among funds beat the S&P 500 Index by more than 85 percentage points since the end of August 2012 when this system went live, returning a cumulative 145% vs. less than 60% for the S&P 500 Index (read the details).

Likewise, other research (not our own) has shown insider purchases are also effective piggybacking methods for investors that lead to greater returns. That’s why we believe investors should pay attention to what hedge funds and insiders are buying and keep them apprised of this information. Let’s take a look at the insider activity on Acuity Brands, Inc. (NYSE:AYI). There were no insider purchase of the stock so far this year, but there were some insiders selling shares of the company the first quarter. Chief Financial Officer Richard Reece sold around 49,350 shares of the company in January. Also during the first quarter, CEO Vernon Nagel sold around 6,300 shares, and Director Robert McCullough sold around 1,800 shares.

With all of this in mind, let’s take a look at the fresh hedge fund activity on Acuity Brands, Inc. (NYSE:AYI).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!